Erin L Glynn1,2, Lucy W Piner2, Kim M Huffman2, Cris A Slentz2,3,4, Lorraine Elliot-Penry2, Hiba AbouAssi3,5, Phillip J White1,2, James R Bain1,2,3,5, Michael J Muehlbauer1,2, Olga R Ilkayeva1,2, Robert D Stevens1,2,3,5, Kathryn N Porter Starr3, Connie W Bales3,6,7, Elena Volpi8, M Julia Brosnan9, Jeff K Trimmer9, Timothy P Rolph9, Christopher B Newgard10,11,12,13,14, William E Kraus15,16,17. 1. Sarah W. Stedman Nutrition & Metabolism Center, Duke University Medical Center, Durham, NC, USA. 2. Duke Molecular Physiology Institute, Duke University Medical Center, 300 North Duke Street, Durham, NC, 27701, USA. 3. Department of Medicine, Duke University Medical Center, Durham, NC, USA. 4. Department of Cardiology, Duke University Medical Center, Durham, NC, USA. 5. Division of Endocrinology, Duke University Medical Center, Durham, NC, USA. 6. Division of Geriatrics, Duke University Medical Center, Durham, NC, USA. 7. GRECC, Durham VA Medical Center, Durham, NC, USA. 8. Sealy Center on Aging, University of Texas Medical Branch, Galveston, TX, USA. 9. The CV and Metabolic Diseases Research Unit, Pfizer, Cambridge, MA, USA. 10. Sarah W. Stedman Nutrition & Metabolism Center, Duke University Medical Center, Durham, NC, USA. Chris.Newgard@dm.duke.edu. 11. Duke Molecular Physiology Institute, Duke University Medical Center, 300 North Duke Street, Durham, NC, 27701, USA. Chris.Newgard@dm.duke.edu. 12. Department of Medicine, Duke University Medical Center, Durham, NC, USA. Chris.Newgard@dm.duke.edu. 13. Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA. Chris.Newgard@dm.duke.edu. 14. Division of Endocrinology, Duke University Medical Center, Durham, NC, USA. Chris.Newgard@dm.duke.edu. 15. Duke Molecular Physiology Institute, Duke University Medical Center, 300 North Duke Street, Durham, NC, 27701, USA. William.Kraus@dm.duke.edu. 16. Department of Medicine, Duke University Medical Center, Durham, NC, USA. William.Kraus@dm.duke.edu. 17. Department of Cardiology, Duke University Medical Center, Durham, NC, USA. William.Kraus@dm.duke.edu.
Abstract
AIMS/HYPOTHESES: Obesity is associated with decreased insulin sensitivity (IS) and elevated plasma branched-chain amino acids (BCAAs). The purpose of this study was to investigate the relationship between BCAA metabolism and IS in overweight (OW) individuals during exercise intervention. METHODS: Whole-body leucine turnover, IS by hyperinsulinaemic-euglycaemic clamp, and circulating and skeletal muscle amino acids, branched-chain α-keto acids and acylcarnitines were measured in ten healthy controls (Control) and nine OW, untrained, insulin-resistant individuals (OW-Untrained). OW-Untrained then underwent a 6 month aerobic and resistance exercise programme and repeated testing (OW-Trained). RESULTS: IS was higher in Control vs OW-Untrained and increased significantly following exercise. IS was lower in OW-Trained vs Control expressed relative to body mass, but was not different from Control when normalised to fat-free mass (FFM). Plasma BCAAs and leucine turnover (relative to FFM) were higher in OW-Untrained vs Control, but did not change on average with exercise. Despite this, within individuals, the decrease in molar sum of circulating BCAAs was the best metabolic predictor of improvement in IS. Circulating glycine levels were higher in Control and OW-Trained vs OW-Untrained, and urinary metabolic profiling suggests that exercise induces more efficient elimination of excess acyl groups derived from BCAA and aromatic amino acid (AA) metabolism via formation of urinary glycine adducts. CONCLUSIONS/ INTERPRETATION: A mechanism involving more efficient elimination of excess acyl groups derived from BCAA and aromatic AA metabolism via glycine conjugation in the liver, rather than increased BCAA disposal through oxidation and turnover, may mediate interactions between exercise, BCAA metabolism and IS. TRIAL REGISTRATION: Clinicaltrials.gov NCT01786941.
AIMS/HYPOTHESES: Obesity is associated with decreased insulin sensitivity (IS) and elevated plasma branched-chain amino acids (BCAAs). The purpose of this study was to investigate the relationship between BCAA metabolism and IS in overweight (OW) individuals during exercise intervention. METHODS: Whole-body leucine turnover, IS by hyperinsulinaemic-euglycaemic clamp, and circulating and skeletal muscle amino acids, branched-chain α-keto acids and acylcarnitines were measured in ten healthy controls (Control) and nine OW, untrained, insulin-resistant individuals (OW-Untrained). OW-Untrained then underwent a 6 month aerobic and resistance exercise programme and repeated testing (OW-Trained). RESULTS: IS was higher in Control vs OW-Untrained and increased significantly following exercise. IS was lower in OW-Trained vs Control expressed relative to body mass, but was not different from Control when normalised to fat-free mass (FFM). Plasma BCAAs and leucine turnover (relative to FFM) were higher in OW-Untrained vs Control, but did not change on average with exercise. Despite this, within individuals, the decrease in molar sum of circulating BCAAs was the best metabolic predictor of improvement in IS. Circulating glycine levels were higher in Control and OW-Trained vs OW-Untrained, and urinary metabolic profiling suggests that exercise induces more efficient elimination of excess acyl groups derived from BCAA and aromatic amino acid (AA) metabolism via formation of urinary glycine adducts. CONCLUSIONS/ INTERPRETATION: A mechanism involving more efficient elimination of excess acyl groups derived from BCAA and aromatic AA metabolism via glycine conjugation in the liver, rather than increased BCAA disposal through oxidation and turnover, may mediate interactions between exercise, BCAA metabolism and IS. TRIAL REGISTRATION: Clinicaltrials.gov NCT01786941.
Entities:
Keywords:
Branched-chain amino acids; Exercise; Insulin resistance; Metabolomics; Obesity; Protein
Authors: Richard D Semba; Marta Gonzalez-Freire; Ruin Moaddel; Kai Sun; Elisa Fabbri; Pingbo Zhang; Olga D Carlson; Mohammed Khadeer; Chee W Chia; Norman Salem; Luigi Ferrucci Journal: J Clin Endocrinol Metab Date: 2018-09-01 Impact factor: 5.958
Authors: M J Leal-Witt; M Ramon-Krauel; S Samino; M Llobet; D Cuadras; J C Jimenez-Chillaron; O Yanes; C Lerin Journal: Int J Obes (Lond) Date: 2017-08-17 Impact factor: 5.095
Authors: William E Kraus; Carl F Pieper; Kim M Huffman; Dana K Thompson; Virginia B Kraus; Miriam C Morey; Harvey J Cohen; Eric Ravussin; Leanne M Redman; James R Bain; Robert D Stevens; Christopher B Newgard Journal: J Gerontol A Biol Sci Med Sci Date: 2016-03-16 Impact factor: 6.053
Authors: Moriah P Bellissimo; Qingpo Cai; Thomas R Ziegler; Ken H Liu; Phong H Tran; Miriam B Vos; Greg S Martin; Dean P Jones; Tianwei Yu; Jessica A Alvarez Journal: Obesity (Silver Spring) Date: 2019-11 Impact factor: 5.002